miRNAs and their potential for use against cancer and other diseases

Author:

Tili Esmerina1,Michaille Jean-Jacques2,Gandhi Varsha3,Plunkett William4,Sampath Deepa4,Calin George Adrian5

Affiliation:

1. Ohio State University, Department of Molecular Virology, Immunology & Medical Genetics and Comprehensive Cancer Center, Columbus, OH 43210, USA.

2. Ohio State University, Department of Molecular Virology, Immunology & Medical Genetics and Comprehensive Cancer Center, Columbus, OH 43210, USA and, INSERM, Université de Bourgogne, Dijon, France.

3. University of Texas, Department of Experimental Therapeutics, TX, USA and, Department of Cancer Genetics, MD Anderson Cancer Center, Houston, TX 77030, USA.

4. University of Texas, Department of Experimental Therapeutics, and, Department of Cancer Genetics, MD Anderson Cancer Center, Houston, TX 77030, USA.

5. University of Texas, Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX 77030, USA.

Abstract

miRNAs are 19–24 nucleotide long noncoding RNAs found in almost all genetically dissected species, including viruses, plants, nematodes, flies, fish, mice and humans. Rapid advances have been made in understanding their physiological functions, while abnormal patterns of miRNA expression have been found in many disease states, most notably human cancer. It is now clear that miRNAs represent a class of genes with a great potential for use in diagnosis, prognosis and therapy. In this review we will focus on the discoveries that elucidate their crucial role in mammalian diseases, particularly in cancer, and propose that miRNA-based gene therapy might become the potential technology of choice in a wide range of human diseases including cancer.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3